<SEC-DOCUMENT>0001104659-22-025691-index.html : 20220222 <SEC-HEADER>0001104659-22-025691.hdr.sgml : 20220222 <ACCEPTANCE-DATETIME>20220222165450 ACCESSION NUMBER: 0001104659-22-025691 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 22659061 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>DEFA14A <SEQUENCE>1 <FILENAME>tm222155d8_defa14a.htm <DESCRIPTION>DEFA14A <TEXT> Document 1 - file: tm222155d8_defa14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tm222155d8_defa14aimg001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tm222155d8_defa14aimg001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tm222155d8_defa14aimg002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tm222155d8_defa14aimg002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm222155d8_defa14aimg003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm222155d8_defa14aimg003.jpg
</DOCUMENT> </SEC-DOCUMENT>